FDA approves Merck vaccine

Order byBest matchMost fresh

FDA, COVID-19 and vaccine

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct...

· 5h · on MSN

Medscape · 1h

FDA Will Prioritize COVID Vaccine Approval for 65 and Older and High Risk

· 2h · on MSN

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

US FDA advisers to consider if new COVID shots should target LP.8.1 subvariant

The U.S. Senate plans to vote this week to bar California's landmark plan to end the sale of gasoline-only vehicles by 2035 that has been adopted by 11 other states, Majority Leader John Thune said on...

· 3h

· 6h

Annual COVID-19 Shots For Healthy Younger Adults, Children Will No Longer Be Routinely Approved

· 7h

US regulators say annual COVID-19 shots for healthy younger adults and children will no longer be routinely approved

Devdiscourse5d

Global Health Headlines: Impactful Investments and Policy Shifts

Sanofi expands its U.S. manufacturing with a $20 billion investment. The FDA approves Merck's cancer drug for rare adrenal tumors. European Court challenges transparency in EU's COVID vaccine negotiations.

The Washington Post5d

FDA to issue new vaccine approval guidance amid questions over coronavirus shots

Send in your questions here. End of carousel The FDA was on track to grant full approval for the vaccine April 1, according to two people familiar with the matter who spoke on the condition of ...

BioSpace1d

FDA Grants Narrow Approval of Novavax’s COVID Shot as Makary Teases Changes to Vaccine Approval Framework

The restrictions on Novavax's vaccine could portend changes at the FDA. Commissioner Marty Makary suggested last week that the agency could update its vaccine approval guidelines “in the coming days.”

US FDA expands use of Merck's cancer drug for adrenal gland tumors

The drug, Welireg, became the first FDA-approved oral treatment for the two tumors — pheochromocytoma and paraganglioma. The regulator's approval was based on a study in which Welireg showed an objective response rate of 20.

Trending on Bing

FDA, COVID-19 and vaccine